Amphastar Pharmaceuticals, Inc. (AMPH)

NASDAQ: AMPH · IEX Real-Time Price · USD
36.23
-0.49 (-1.33%)
May 26, 2022 3:59 PM EDT - Market closed

Company Description

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency.

The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures.

In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block.

Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices.

The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Amphastar Pharmaceuticals, Inc.
CountryUnited States
Founded1996
IPO DateJun 25, 2014
IndustryPharmaceuticals
SectorHealth Care
Employees1,761
CEOJack Zhang

Contact Details

Address:
11570 6th St
Rancho Cucamonga, California 91730-6025
United States
Phone909 980 9484
Websiteamphastar.com

Stock Details

Ticker SymbolAMPH
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code0001297184

Key Executives

NamePosition
Dr. Ziping Luo Ph.D.Chairman, Chief Scientist and Chief Operating Officer
Dr. Yongfeng Zhang Ph.D.Co-Founder, President, Chief Executive Officer, Chief Scientific Officer and Director
William J. Peters M.B.A.Chief Financial Officer, Executive Vice President of Finance and Treasurer
Jacob Liawatidewi M.B.A.Executive Vice President of Sales, Marketing and Corporate Administrative Center and Corporate Secretary
Rong Zhou M.S.Executive Vice President of Production Center
Dan DischnerVice President of Corporate Communications
Tony MarrsSenior Vice President of Regulatory Affairs and Clinical Operations
Peter LangoshVice President of Operational Improvement and Vice President of Internal Audit

Latest SEC Filings

DateTypeTitle
May 23, 20224Statement of changes in beneficial ownership of securities
May 20, 20224Statement of changes in beneficial ownership of securities
May 20, 20224Statement of changes in beneficial ownership of securities
May 19, 20224Statement of changes in beneficial ownership of securities
May 18, 20224Statement of changes in beneficial ownership of securities
May 17, 20224Statement of changes in beneficial ownership of securities
May 9, 202210-QQuarterly report [Sections 13 or 15(d)]
May 9, 20228-KCurrent report
May 3, 20224Statement of changes in beneficial ownership of securities
Apr 22, 20228-KCurrent report
View All SEC Filings